Omnipod 5
Tubeless insulin pod automates delivery from compatible CGM readings through an app or controller.
Keep in mind Compatibility is system, firmware and market dependent. No dosing or treatment recommendation is made.
Compare wearables
Compare up to 10 devices across categories. Keep the purpose and the source beside the numbers.
Search & choose modelsAdd models to your comparison
Build your comparison
2 / 10 models676 models available. Showing nine - search to narrow the list.
Comparison settingsMarket, sorting & differences
How price order works
Lowest recorded store prices take priority over announced or launch prices, within the selected source market. Currencies use the dated EUR reference rates. Deposits and recurring charges are excluded from price order; missing prices stay last. Original price records remain visible.
At a glance
The differences that matter
Tandem t:slim X2
Prescription subcutaneous insulin delivery; regional Control-IQ+ eligibility applies.
Keep in mind US manufacturer pump indication: ages 2+. Control-IQ+ type 1 indication is ages 2+ and type 2 indication ages 18+; CGM age limits can be different.
Published specifications and documented constraints. See the full comparison below for prices and sources.
Scroll across the table to compare every model
| Biosensors & healthAdd a model |  |  |
|---|---|---|
| Prices · all markets | Price not verified 0 offer records & sourcesNo verified price in this audit. | Price not verified 0 offer records & sourcesNo verified price in this audit. |
| Designed for | Tubeless insulin pod automates delivery from compatible CGM readings through an app or controller. ↗ | Prescription subcutaneous insulin delivery; regional Control-IQ+ eligibility applies. ↗ |
| Form factor | Wearable disposable insulin Pod ↗ | Touchscreen wearable insulin pump with infusion tubing ↗ |
| Power & output | Not verified | Rechargeable battery ↗ |
| Water / dust rating | Pod IP28, up to 25 ft for 60 min; controller not waterproof ↗ | Not verified |
| Software | Not verified | In-warranty software updates subject to eligibility/training ↗ |
| Wear Duration | Up to 72 hours ↗ | Not applicable to this category |
| Capacity | Up to 200 units U-100 rapid-acting insulin ↗ | Not applicable to this category |
| Dosing | Automatic adjustments every five minutes ↗ | Not applicable to this category |
| USIndication | Type 1 diabetes ages 2+; type 2 diabetes ages 18+ ↗ | Not applicable to this category |
| Controller | Compatible smartphone app or supplied controller ↗ | Not applicable to this category |
| CGM | Dexcom G7 systems, Libre 3 Plus and Libre 2 Plus per current US page ↗ | Not applicable to this category |
| Target Glucose | US page lists customizable 100-150 mg/dL ↗ | Not applicable to this category |
| Reservoir | Not applicable to this category | 300 units ↗ |
| Control | Not applicable to this category | Colour touchscreen; compatible mobile bolus option ↗ |
| Profiles | Not applicable to this category | Up to six personal profiles with timed segments ↗ |
| Cgms | Not applicable to this category | Maker currently lists Dexcom G7 systems and FreeStyle Libre 3 Plus; configuration dependent ↗ |
| Algorithm | Not applicable to this category | Control-IQ+ ↗ |
| Availability | Prescription/benefits check and compatible CGM required; pharmacy access varies by coverage. | Exact manufacturer model verified; market and purchase eligibility follow the linked manufacturer source. |
| Important context |
|
|
| Editorial pick & release | No editorial ranking recorded | No editorial ranking recorded |
| Evidence | Manufacturer source Checked 2026-10-13 | Manufacturer source Checked 2026-10-12 |
Battery claims use different conditions and are not a controlled benchmark. “Not verified” is an evidence gap, not a missing feature. Prices are dated regional snapshots. Deposits, bundles and historical launch prices are labelled. Brightness measurement methods and battery workloads vary by manufacturer.